Abstract
The study of the expression and the tissue distribution of the tyrosine kinase drug-target epidermal growth factor receptor (EGFR) is of interest in oncology as a marker of potential efficacy of treatment. It has been reported, however, that the response rates to anti-EGFR drugs are poorly linked to its expression. Clinical studies have also revealed a patient response correlation with the expression levels of two EGFR ligands; amphiregulin and epiregulin. Here, we report the development of a matrix-assisted laser desorption/ionisation mass spectrometry imaging methodology for the study of EGFR, epiregulin and amphiregulin distribution in formalin fixed paraffin embedded human placental tissue and a comparison to expression patterns obtained by immunohiostochemistry. Using on-tissue digests and imaging of specific peptides, the tissue distribution of these proteins has been obtained down to 30 μm spatial resolution.
| Original language | English |
|---|---|
| Pages (from-to) | 17-28 |
| Number of pages | 12 |
| Journal | European Journal of Mass Spectrometry |
| Volume | 19 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2013 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Amphiregulin
- Cetuximab
- Colorectal cancer
- EGFR
- Epiregulin
- FFPE
- Immunohistochemistry
- Maldi
- Panitumumab
- Placenta
- Recombinant cancer therapeutics
- Targeted drugs
- Tissue imaging
Fingerprint
Dive into the research topics of 'Detection of the epidermal growth factor receptor, amphiregulin and epiregulin in formalin-fixed paraffin-embedded human placenta tissue by matrix-assisted laser desorption/ionization mass spectrometry imaging'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver